Table 1.

The changes of paracrine cytokines in MSCs in each group

Protein information	B/A (fold)	C/A (fold)	D/A (fold)	E/A (fold)	F/A (fold)
MCP-1	1.34	1.12	1.24	1.52*	1.17
TRAIL	0.81	0.46*,#,Δ	0.77	0.79	0.70
MIP-2	1.52*	1.36	1.41	0.99	1.07
CINC-2 alpha/beta	1.01	0.98	1.56*	0.97	1.01
CD106	1.12	0.79	1.06	0.88	1.07
Activin A	1.53*,Δ	1.43*,Δ	0.99	1.63*,Δ	1.32*,Δ
MDC	0.82	0.73	1.13	0.83	1.30
Adiponectin/Acrp30	0.78	0.78	1.01	1.10	1.23
IL-4	1.02	0.87	1.17	0.93	1.20
RALT/MIG-6	1.05	0.87	0.91	0.94	1.19
IL-10	1.12	1.01	1.29	1.07	1.31
Integrin alpha M beta 2	1.15	1.00	1.14	1.85*,#,Δ	3.62*,#,Δ
GM-CSF	1.22	1.06	1.28	1.06	1.30
TGF-beta3	1.02	1.01	1.11	1.08	1.44*,#,Δ
GFR alpha-2	1.28	1.03	1.24	1.09	1.32
MIP-1 alpha	1.73*,Δ	1.83*,Δ	0.89	1.42*,Δ	1.48*,Δ
IL-6	1.34	1.18	1.37	1.09	1.32
EG-VEGF/PK1	1.03	0.87	1.09	0.98	1.27
TLR4	1.14	1.00	0.84	1.07	1.52*,#,Δ
Prolactin R	0.81	0.72	1.08	0.86	1.12
Thrombospondin	1.03	1.09	1.23	1.39*,#	1.70*,#
IL-1 beta	1.07	1.12	1.50	1.25	1.48
IL-5	1.02	0.77	0.94	0.86	1.13
IP-10	1.20	1.16	1.38	1.27	1.75*,#
MIF	1.60*,#,Δ	1.08	1.04	1.27	1.72*,#,Δ
TIMP-2	1.17	0.94	0.97	1.07	2.06*,#,Δ
Insulin Degrading Enzyme	1.13	1.19	1.19	1.32	4.27*,#,Δ

A: control group; B: low-dose PMA group; C: high-dose PMA group; D: PKCε inhibiting group; E: CXCR4 antagonist group; F: PI3K inhibiting group.

^* P < 0.05 vs. the control;

^# P < 0.05 vs. group C;

^Δ P < 0.05 vs. group D.